Cargando…
The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous system leading to destruction of myelin sheaths. Natalizumab is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin which has been approved for treatment of relapsing forms of MS. This...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265353/ https://www.ncbi.nlm.nih.gov/pubmed/30498920 http://dx.doi.org/10.1186/s40169-018-0216-3 |